A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Castration-Resistant Prostate Cancer

NCT01228760 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Neoplasms

Interventions

DRUG: ASG-5ME

Sponsor

Astellas Pharma Inc

Collaborators

[object Object]